PCN-5603

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePCN-5603
Drug Alias NamePCN-5603
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsLeukemia, Myeloid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPiramed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPiramed
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid

Other Information

ATC CodeN/A
Related LinksN/A